• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超氧化物歧化酶可减少再灌注心律失常,并在使用组织纤溶酶原激活剂进行溶栓治疗期间维持心肌功能。

Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator.

作者信息

Mehta J L, Nichols W W, Saldeen T G, Chandna V K, Nicolini F A, Lawson D L, ter Riet M F

机构信息

Department of Medicine, University of Florida College of Medicine, Gainesville.

出版信息

J Cardiovasc Pharmacol. 1990 Jul;16(1):112-20. doi: 10.1097/00005344-199007000-00016.

DOI:10.1097/00005344-199007000-00016
PMID:1696653
Abstract

Release of superoxide radicals during the early phase of coronary reperfusion may result in degradation of endothelium-derived relaxing factor (EDRF), extension of myocardial injury, precipitation of arrhythmias, and stimulation of platelet aggregation. These factors may relate to the occurrence of ventricular fibrillation during reperfusion and coronary reocclusion following initial thrombolysis. This study was designed to examine the effects of concomitant administration of superoxide radical scavenger superoxide dismutase (SOD) with tissue plasminogen activator (tPA) compared to tPA alone (without SOD) in acute coronary thrombosis in anesthetized dogs. Dogs with a stable electrically induced coronary thrombus were randomly given intravenously tPA (0.75 mg/kg) alone or SOD bolus (2 mg/kg) followed by SOD (4 mg/kg) + tPA (0.75 mg/kg) over 20 min. tPA alone restored coronary blood flow in six of nine dogs (reperfusion rate of 67%) with time to reflow of 18.5 +/- 6.7 (mean +/- SD) min. Coronary reocclusion occurred spontaneously in four of six dogs with initial reperfusion (reocclusion rate of 67%). In contrast, SOD + tPA restored coronary blood flow in 9 of 12 dogs (reperfusion rate of 75%, not significant vs. tPA alone) with time to reflow of 11.3 +/- 4.8 min and coronary reocclusion occurred in only 3 of 9 dogs with reperfusion (reocclusion rate of 33%, not significant vs. tPA alone). Reperfusion arrhythmias were more frequent in dogs who received tPA alone compared to those who received SOD in addition to tPA (mean Holter-monitored PVC count of 730 vs. 12 beats/h, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

冠状动脉再灌注早期超氧自由基的释放可能导致内皮源性舒张因子(EDRF)降解、心肌损伤加重、心律失常以及血小板聚集。这些因素可能与再灌注期间室颤的发生以及初始溶栓后冠状动脉再闭塞有关。本研究旨在检测与单独使用组织型纤溶酶原激活剂(tPA)(不使用超氧化物歧化酶(SOD))相比,在麻醉犬急性冠状动脉血栓形成中联合使用超氧自由基清除剂超氧化物歧化酶(SOD)与组织型纤溶酶原激活剂(tPA)的效果。患有稳定电诱导冠状动脉血栓的犬被随机静脉注射单独的tPA(0.75mg/kg)或先给予SOD推注(2mg/kg),随后在20分钟内给予SOD(4mg/kg)+tPA(0.75mg/kg)。单独使用tPA使9只犬中的6只恢复了冠状动脉血流(再灌注率为67%),再灌注时间为18.5±6.7(均值±标准差)分钟。6只初始再灌注的犬中有4只自发发生冠状动脉再闭塞(再闭塞率为67%)。相比之下,SOD+tPA使12只犬中的9只恢复了冠状动脉血流(再灌注率为75%,与单独使用tPA相比无显著差异),再灌注时间为11.3±4.8分钟,9只再灌注犬中只有3只发生冠状动脉再闭塞(再闭塞率为33%,与单独使用tPA相比无显著差异)。与除tPA外还接受SOD的犬相比,单独接受tPA的犬再灌注心律失常更频繁(动态心电图监测的室性早搏平均计数为730次/小时对12次/小时,p<0.01)。(摘要截短于250字)

相似文献

1
Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator.超氧化物歧化酶可减少再灌注心律失常,并在使用组织纤溶酶原激活剂进行溶栓治疗期间维持心肌功能。
J Cardiovasc Pharmacol. 1990 Jul;16(1):112-20. doi: 10.1097/00005344-199007000-00016.
2
Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.氧自由基清除剂在犬冠状动脉溶栓模型中作为组织型纤溶酶原激活剂辅助治疗的研究
Cardiovasc Res. 1993 Jun;27(6):925-34. doi: 10.1093/cvr/27.6.925.
3
Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator.使用组织纤溶酶原激活剂的新型突变体K2P对患有冠状动脉血栓形成的犬进行持续再灌注。
J Am Coll Cardiol. 1992 Jul;20(1):228-35. doi: 10.1016/0735-1097(92)90164-i.
4
Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis.冠状动脉血栓形成和溶栓后心肌中性粒细胞浸润、脂质过氧化及抗氧化活性
Am Heart J. 1995 Feb;129(2):211-8. doi: 10.1016/0002-8703(95)90000-4.
5
Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator.在犬冠状动脉血栓形成模型中抑制因子XIIIa:对重组组织型纤溶酶原激活剂治疗后再灌注及急性再闭塞的影响
Blood. 1990 Apr 1;75(7):1455-9.
6
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.硝酸甘油联合治疗未能提高组织型纤溶酶原激活剂对冠状动脉血栓形成疗效的病理基础。
Cardiovasc Res. 1991 Apr;25(4):283-9. doi: 10.1093/cvr/25.4.283.
7
Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis.前列环素类似物伊洛前列素降低犬冠状动脉血栓形成中组织型纤溶酶原激活剂的溶栓潜力。
Circulation. 1990 Mar;81(3):1115-22. doi: 10.1161/01.cir.81.3.1115.
8
Prevention of reocclusion following tissue type plasminogen activator-induced thrombolysis by the RGD-containing peptide, echistatin, in a canine model of coronary thrombosis.在犬冠状动脉血栓形成模型中,含RGD肽echistatin对组织型纤溶酶原激活剂诱导的溶栓后再闭塞的预防作用。
Pharmacology. 1991;42(6):340-8. doi: 10.1159/000138817.
9
Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs.在犬类中,重组组织型纤溶酶原诱导溶栓后,前列环素类似物伊洛前列素未能维持冠状动脉血流。
Am Heart J. 1993 Aug;126(2):285-92. doi: 10.1016/0002-8703(93)91041-c.
10
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Circulation. 1989 Apr;79(4):911-9. doi: 10.1161/01.cir.79.4.911.

引用本文的文献

1
Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis.组织型纤溶酶原激活物在合并或不合并主动脉瓣钙化的冠状动脉疾病中的预后作用。
ESC Heart Fail. 2023 Aug;10(4):2541-2549. doi: 10.1002/ehf2.14420. Epub 2023 Jun 12.
2
Autophagy, a process within reperfusion injury: an update.自噬,再灌注损伤中的一个过程:最新进展
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8322-41. eCollection 2014.
3
Mitochondrial therapeutics for cardioprotection.线粒体治疗心脏病学。
Curr Pharm Des. 2011;17(20):2017-35. doi: 10.2174/138161211796904777.
4
Ventricular arrhythmias and mortality associated with isoflurane and sevoflurane in a porcine model of myocardial infarction.在猪心肌梗死模型中,异氟烷和七氟烷相关的室性心律失常及死亡率
J Am Assoc Lab Anim Sci. 2011 Jan;50(1):73-8.
5
The plasminogen activator system modulates sympathetic nerve function.纤溶酶原激活物系统调节交感神经功能。
J Exp Med. 2006 Sep 4;203(9):2191-200. doi: 10.1084/jem.20060077. Epub 2006 Aug 28.
6
Myocardial Reperfusion Injury: From Bench to Bedside.心肌再灌注损伤:从 bench 到 bedside(此处 bench 和 bedside 可能有特定专业含义,直译为“实验台”和“病床边”,可结合专业背景理解为从基础研究到临床应用)
J Thromb Thrombolysis. 1997 Jan;4(1):35-37. doi: 10.1023/a:1017573728821.
7
Does the antiarrhythmic effect of DMPO originate from its oxygen radical trapping property or the structure of the molecule itself?DMPO的抗心律失常作用是源于其氧自由基捕获特性还是分子本身的结构?
Basic Res Cardiol. 1992 Nov-Dec;87(6):536-47. doi: 10.1007/BF00788664.